Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -4123.80% is 436% below its 4-year average of -768.81%, near the low end of its 4-year range (-4123.80%–-90.74%).
560.17% below its 12-month average of -624.65%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -840.21%.
RETURN ON ASSETS (ROA)
-4123.80%
RETURN ON ASSETS (ROA) AVG TTM
-624.65%
RETURN ON ASSETS (ROA) AVG 3Y
-938.33%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-560.17%
CURRENT VS 3Y AVG
-339.48%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 717 covered companies
CURRENT VS SECTOR MEDIAN
-13332.57%
vs the sector median at left
Profusa, Inc. Common Stock
Market Cap
$1.80M
Return on Assets (ROA)
-4123.80%
TTM Avg
-624.65%
3Y Avg
-938.33%
5Y Avg
N/A
Market Cap
$1.82M
Return on Assets (ROA)
-28.33%
TTM Avg
-125.52%
3Y Avg
-210.32%
5Y Avg
-182.20%
Market Cap
$1.95M
Return on Assets (ROA)
-404.67%
TTM Avg
-168.15%
3Y Avg
-182.58%
5Y Avg
-275.93%
Market Cap
$1.49M
Return on Assets (ROA)
-148.13%
TTM Avg
-399.46%
3Y Avg
-266.31%
5Y Avg
-266.31%
Market Cap
$1.47M
Return on Assets (ROA)
-36.88%
TTM Avg
-64.67%
3Y Avg
-76.84%
5Y Avg
-289.12%
Market Cap
$1.47M
Return on Assets (ROA)
-111.51%
TTM Avg
-71.56%
3Y Avg
-64.13%
5Y Avg
-49.86%
Market Cap
$1.42M
Return on Assets (ROA)
-20.46%
TTM Avg
-67.47%
3Y Avg
-117.99%
5Y Avg
-101.96%
Market Cap
$1.40M
Return on Assets (ROA)
-23.39%
TTM Avg
-29.27%
3Y Avg
-34.02%
5Y Avg
-43.63%
Market Cap
$1.33M
Return on Assets (ROA)
-72.52%
TTM Avg
-80.61%
3Y Avg
-249.55%
5Y Avg
-240.26%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profusa, Inc. Common Stock (PFSA) | $1.80M | -4123.80% | -624.65% | -938.33% | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.82M | -28.33% | -125.52% | -210.32% | -182.20% |
| Autonomix Medical, Inc. (AMIX)vs › | $1.95M | -404.67% | -168.15% | -182.58% | -275.93% |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.49M | -148.13% | -399.46% | -266.31% | -266.31% |
| PMGC Holdings Inc. (ELAB)vs › | $1.47M | -36.88% | -64.67% | -76.84% | -289.12% |
| Curis, Inc. (CRIS)vs › | $1.47M | -111.51% | -71.56% | -64.13% | -49.86% |
| INVO Fertility, Inc. (IVF)vs › | $1.42M | -20.46% | -67.47% | -117.99% | -101.96% |
| NEXGEL, Inc. (NXGL)vs › | $1.40M | -23.39% | -29.27% | -34.02% | -43.63% |
| NewcelX Ltd. (NCEL)vs › | $1.33M | -72.52% | -80.61% | -249.55% | -240.26% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.39M | -196.18% | -334.48% | -197.38% | -169.68% |
ROA
-4123.8%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -948.95% |
| 2024-12-31 | -300.36% |
| 2023-12-31 | -543.11% |
| 2022-12-31 | -1960.91% |
| 2021-12-31 | -90.74% |
